Advertisement
Loading...

Alpha Teknova, Inc.

TKNO•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$3.51
$-0.21(-5.65%)
U.S. Market opens in 28h 24m

Alpha Teknova, Inc. (TKNO) Stock Overview

Explore Alpha Teknova, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap188.2M
P/E Ratio-11.08
EPS (TTM)$-0.31
ROE-0.24%
Fundamental Analysis

AI Price Forecasts

1 Month$2.59
3 Months$0.00
1 Year Target$1.51

TKNO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Alpha Teknova, Inc. (TKNO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.75, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.51.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.08 and a market capitalization of 188.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-5.65%
5-Day Change
-12.47%
1-Month Change
28.10%
3-Month Change
75.50%
6-Month Change
-21.12%
Year-to-Date (YTD) Change
-7.63%
1-Year Change
-46.08%
3-Year Change
78.17%
5-Year Change
-85.96%
All-Time (Max) Change
-85.96%

Contact Information

https://www.teknova.com
831 637 1100
2290 Bert Drive, Hollister, CA, 95023

Company Facts

173 Employees
IPO DateJun 25, 2021
CountryUS
Actively Trading

Frequently Asked Questions